Medtronic PLC Valuation
| 2M6 Stock | EUR 85.36 1.05 1.25% |
At this time, the firm appears to be undervalued. Medtronic PLC secures a last-minute Real Value of €90.91 per share. The latest price of the firm is €85.36. Our model forecasts the value of Medtronic PLC from analyzing the firm fundamentals such as Profit Margin of 0.13 %, current valuation of 113.84 B, and Return On Equity of 0.0784 as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Medtronic PLC's price fluctuation is very steady at this time. Calculation of the real value of Medtronic PLC is based on 3 months time horizon. Increasing Medtronic PLC's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Medtronic stock is determined by what a typical buyer is willing to pay for full or partial control of Medtronic PLC. Since Medtronic PLC is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Medtronic Stock. However, Medtronic PLC's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 85.36 | Real 90.91 | Hype 85.36 | Naive 83.08 |
The real value of Medtronic Stock, also known as its intrinsic value, is the underlying worth of Medtronic PLC Company, which is reflected in its stock price. It is based on Medtronic PLC's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Medtronic PLC's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Medtronic PLC helps investors to forecast how Medtronic stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Medtronic PLC more accurately as focusing exclusively on Medtronic PLC's fundamentals will not take into account other important factors: Medtronic PLC Total Value Analysis
Medtronic PLC is presently estimated to have takeover price of 113.84 B with market capitalization of 103.37 B, debt of 20.37 B, and cash on hands of 9.85 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Medtronic PLC fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
113.84 B | 103.37 B | 20.37 B | 9.85 B |
Medtronic PLC Investor Information
About 85.0% of the company shares are owned by institutions such as pension funds. The company has Price-to-Book (P/B) ratio of 1.99. In the past many companies with similar price-to-book ratios have beat the market. Medtronic PLC has Price/Earnings To Growth (PEG) ratio of 3.0. The entity last dividend was issued on the 20th of December 2022. Based on the measurements of operating efficiency obtained from Medtronic PLC's historical financial statements, Medtronic PLC is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.Medtronic PLC Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Medtronic PLC has an asset utilization ratio of 34.83 percent. This implies that the Company is making €0.35 for each dollar of assets. An increasing asset utilization means that Medtronic PLC is more efficient with each dollar of assets it utilizes for everyday operations.Medtronic PLC Ownership Allocation
Medtronic PLC maintains a total of 1.33 Billion outstanding shares. The majority of Medtronic PLC outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Medtronic PLC to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Medtronic PLC. Please pay attention to any change in the institutional holdings of Medtronic PLC as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Medtronic PLC Profitability Analysis
The company reported the revenue of 31.69 B. Net Income was 5.04 B with profit before overhead, payroll, taxes, and interest of 21.71 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Medtronic PLC's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Medtronic PLC and how it compares across the competition.
About Medtronic PLC Valuation
The stock valuation mechanism determines Medtronic PLC's current worth on a weekly basis. Our valuation model uses a comparative analysis of Medtronic PLC. We calculate exposure to Medtronic PLC's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Medtronic PLC's related companies.Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. The company was founded in 1949 and is headquartered in Dublin, Ireland. MEDTRONIC PLC operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 101013 people.
8 Steps to conduct Medtronic PLC's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Medtronic PLC's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Medtronic PLC's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Medtronic PLC's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Medtronic PLC's revenue streams: Identify Medtronic PLC's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Medtronic PLC's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Medtronic PLC's growth potential: Evaluate Medtronic PLC's management, business model, and growth potential.
- Determine Medtronic PLC's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Medtronic PLC's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Medtronic Stock analysis
When running Medtronic PLC's price analysis, check to measure Medtronic PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medtronic PLC is operating at the current time. Most of Medtronic PLC's value examination focuses on studying past and present price action to predict the probability of Medtronic PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medtronic PLC's price. Additionally, you may evaluate how the addition of Medtronic PLC to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |